114 related articles for article (PubMed ID: 9922511)
1. [Surface characteristics and antimicrobial sensitivity of clinical strains of Acinetobacter spp].
Martínez MA; Pinto ME; Zemelman R; Cifras LA; Lira G; Ramírez C
Rev Med Chil; 1998 Sep; 126(9):1079-84. PubMed ID: 9922511
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial resistance of different Acinetobacter baumannii biotypes isolated in the northern region of Chile].
Silva J; Avello C; Matamoro F; Villagra L; Rojas V; Sandoval L
Rev Med Chil; 1999 Aug; 127(8):926-34. PubMed ID: 10752253
[TBL] [Abstract][Full Text] [Related]
3. [Identification and sensitivity of acinetobacter sp isolated from clinical specimens and hospital environment].
Martínez MA; Pinto ME; Giglio MS; Pommier J; Muñoz LM
Rev Med Chil; 1992 Nov; 120(11):1267-72. PubMed ID: 1340947
[TBL] [Abstract][Full Text] [Related]
4. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P
J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A
Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility.
Wisplinghoff H; Edmond MB; Pfaller MA; Jones RN; Wenzel RP; Seifert H
Clin Infect Dis; 2000 Sep; 31(3):690-7. PubMed ID: 11017817
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
[TBL] [Abstract][Full Text] [Related]
8. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
Tognim MC; Andrade SS; Silbert S; Gales AC; Jones RN; Sader HS
Int J Infect Dis; 2004 Sep; 8(5):284-91. PubMed ID: 15325597
[TBL] [Abstract][Full Text] [Related]
9. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
López-Hernández S; Alarcón T; López-Brea M
Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706
[TBL] [Abstract][Full Text] [Related]
10. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
11. Relationship between antimicrobial resistance and aminoglycoside-modifying enzyme gene expressions in Acinetobacter baumannii.
Shi WF; Jiang JP; Mi ZH
Chin Med J (Engl); 2005 Jan; 118(2):141-5. PubMed ID: 15667800
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of nosocomial infection associated with multi-resistant Acinetobacter baumannii by infrequent-restriction-site PCR.
Wu TL; Su LH; Leu HS; Chiu CH; Chiu YP; Chia JH; Kuo AJ; Sun CF
J Hosp Infect; 2002 May; 51(1):27-32. PubMed ID: 12009817
[TBL] [Abstract][Full Text] [Related]
13. Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species.
Kawamura-Sato K; Wachino J; Kondo T; Ito H; Arakawa Y
J Antimicrob Chemother; 2010 Sep; 65(9):1975-83. PubMed ID: 20576639
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility pattern of Acinetobacter species to commonly used cephalosporins, quinolones, and aminoglycosides.
Prashanth K; Badrinath S
Indian J Med Microbiol; 2004; 22(2):97-103. PubMed ID: 17642704
[TBL] [Abstract][Full Text] [Related]
15. Distribution and in vitro antimicrobial susceptibility of Acinetobacter species on the skin of healthy humans.
Patil JR; Chopade BA
Natl Med J India; 2001; 14(4):204-8. PubMed ID: 11547525
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-beta-lactamase].
Ait El Kadi M; Aghrouch M; Seffar M; El harti J; Bouklouze A; Cherrah Y; Souly K; Zouhdi M
Med Mal Infect; 2006 Jul; 36(7):386-9. PubMed ID: 16842953
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanism of multiple-drug and pan-drug resistance among Acinetobacter species].
Wang H; Sun HL; Ning YZ; Yang QW; Chen MJ; Zhu YJ; Xu YC; Xie XL
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):17-22. PubMed ID: 16606529
[TBL] [Abstract][Full Text] [Related]
18. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
[TBL] [Abstract][Full Text] [Related]
19. Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.
Lee K; Ha GY; Shin BM; Kim JJ; Kang JO; Jang SJ; Yong D; Chong Y;
Diagn Microbiol Infect Dis; 2004 Sep; 50(1):51-8. PubMed ID: 15380278
[TBL] [Abstract][Full Text] [Related]
20. Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections.
Berlau J; Aucken HM; Houang E; Pitt TL
J Hosp Infect; 1999 Jul; 42(3):201-4. PubMed ID: 10439992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
